Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Y. Renaudineau, E. Grunebaum, I. Krause, Sonja Praprotnik, R. Revelen, P. Youinou, M. Blanks, B. Gilburd, Y. Sherer, C. Luderschmidt, A. Eldor, B. Weksler, E. M. Gershwin & Y. Shoenfeld. (2001) Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies. Autoimmunity 33:3, pages 171-179.
Read now
Read now
Howard Fillit, Shinobu Shibata, Takeshi Sasaki, Harry Spiera, Leslie D. Kerr & Milan Blake. (1993) Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus. Autoimmunity 14:3, pages 243-249.
Read now
Read now
Articles from other publishers (21)
Mark B. Zimering. (2010) Recurrent Macular Edema and Stroke Syndrome in Type 1 Diabetes Mellitus with Potent Endothelial Cell Inhibitory Autoantibodies. Endocrine Practice 16:5, pages 842-850.
Crossref
Crossref
Valeria Rossetto, Luca Spiezia, Francesca Franz, Laura Salmaso, Laura Visonà Dalla Pozza, Sabrina Gavasso & Paolo Simioni. (2009) The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. American Journal of Hematology 84:9, pages 594-596.
Crossref
Crossref
Mark B. Zimering, Robert J. Anderson, Thomas E. Moritz & Ling Ge. (2009) Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes Trial. Metabolism 58:6, pages 882-887.
Crossref
Crossref
Mark B. Zimering, Robert J. Anderson, Thomas E. Moritz & Ling Ge. (2009) Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial. Metabolism 58:3, pages 393-400.
Crossref
Crossref
C KRAMERS, R M TERMAAT, E J ter BORG, M C J van BRUGGEN, C G M KALLENBERG & J H M BERDEN. (1993) Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis. Clinical and Experimental Immunology 93:1, pages 34-38.
Crossref
Crossref
Yaniv Sherer, Alexander Gorstein, Marvin J. Fritzler & Yehuda Shoenfeld. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 34:2, pages 501-537.
Crossref
Crossref
N Ziouti, I.-E Triantaphyllidou, M Assouti, N Papageorgakopoulou, D Kyriakopoulou, S.Th Anagnostides & D.H Vynios. (2004) Solid phase assays in glycoconjugate research: applications to the analysis of proteoglycans, glycosaminoglycans and metalloproteinases. Journal of Pharmaceutical and Biomedical Analysis 34:4, pages 771-789.
Crossref
Crossref
Michael Briones & Thomas Abshire. (2003) Lupus anticoagulants in children. Current Opinion in Hematology 10:5, pages 375-379.
Crossref
Crossref
Pier Meroni, Elena Raschi & Nicoletta Del Papa. 2001. Vascular Manifestations of Systemic Autoimmune Diseases. Vascular Manifestations of Systemic Autoimmune Diseases.
Robert Roubey. 2001. Vascular Manifestations of Systemic Autoimmune Diseases. Vascular Manifestations of Systemic Autoimmune Diseases.
Marta E. Martinuzzo, Ricardo R. Forastiero, Yolanda Adamczuk, Gonzalo Pombo & Luis O. Carreras. (1999) Antiplatelet Factor 4—Heparin Antibodies in Patients with Antiphospholipid Antibodies. Thrombosis Research 95:6, pages 271-279.
Crossref
Crossref
Chandra Mohan, Laurence Morel, Ping Yang, Hiroshi Watanabe, Byron Croker, Gary Gilkeson & Edward K. Wakeland. (1999) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. Journal of Clinical Investigation 103:12, pages 1685-1695.
Crossref
Crossref
Gowthami Arepally & Douglas B. Cines. 1999. The Decade of Autoimmunity. The Decade of Autoimmunity
157
168
.
Robert A. S. Roubey. 1999. Lupus. Lupus
471
491
.
Y Renaudineau, R Revelen, A Bordron, D Mottier, P Youinou & R Le Corre. (2016) Two populations of endothelial cell antibodies cross-react with heparin. Lupus 7:2, pages 86-94.
Crossref
Crossref
George T. Nahass. (1997) Antiphospholipid antibodies and the antiphospholipid antibody syndrome. Journal of the American Academy of Dermatology 36:2, pages 149-171.
Crossref
Crossref
Mieke C.J. van Bruggen, Birgitte Walgreen, Truus P.M. Rijke, Marc J.A.M.M. Corsius, Karel J.M. Assmann, Ruud J.T. Smeenk, Gijs W.K. van Dedem, Kees Kramers & Jo H.M. Berden. (1996) Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney International 50:5, pages 1555-1564.
Crossref
Crossref
Robert A. S. Roubey. (2005) Immunology of the antiphospholipid antibody syndrome. Arthritis & Rheumatism 39:9, pages 1444-1454.
Crossref
Crossref
Wil J.M. Tax, Cornelis Kramers, Mieke C.J. van Bruggen & Jo H.M. Berden. (1995) Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney International 48:3, pages 666-673.
Crossref
Crossref
Robert A. S. Roubey. 1995. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
81
92
.
Jeanette H. Magnus, Tore Stenstad & Gunnar Husby. (1994) Proteoglycans, glycosaminoglycans and amyloid deposition. Baillière's Clinical Rheumatology 8:3, pages 575-597.
Crossref
Crossref